SAM
GNCA

Sectoral Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Sectoral Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,117
Closed -$26K – 161
2018
Q3 		$26K Buy
+4,117
New +$21.7K ﹤0.01% 166

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sectoral Asset Management's GNCA Position: Q4 2018 in Review

Sectoral Asset Management sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2018, closing a stake of 4,117 shares — an estimated $26K sold.

Sectoral Asset Management first reported a position in GNCA in Q3 2018 and held it in 1 quarter. The position peaked at $26K in Q3 2018. 43 funds tracked by Wall St. Rank hold GNCA as of Q4 2018.

  • Sectoral Asset Management reported no remaining Genocea Biosciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • Sectoral Asset Management sold 4,117 Genocea Biosciences, Inc. shares in Q4 2018, an estimated $26K.
  • Sectoral Asset Management first reported a position in Genocea Biosciences, Inc. in Q3 2018 and held it in 1 quarter.
  • Sectoral Asset Management's Genocea Biosciences, Inc. position peaked at $26K in Q3 2018.
  • 43 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.